Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529609502> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2529609502 endingPage "S203" @default.
- W2529609502 startingPage "S203" @default.
- W2529609502 abstract "BackgroundObstructive sleep apnea (OSA) is common in patients with congestive heart failure (CHF) and can contribute to disease progression. Continuous positive airway pressure (CPAP) is used to treat OSA and has been shown to improve left ventricular function in CHF patients. However, the effects of CPAP therapy on right ventricular (RV) function, an independent predictor of outcome in CHF patients, are not known.MethodsIn this randomized controlled trial, 45 patients with OSA (apnea/hypopnea index >10 events/hour by nocturnal polysomnography) and stable CHF (left ventricular ejection fraction ≤45% and at least NYHA Class II symptoms) were randomized to receive CPAP (n=22) or no CPAP (n=23) therapy. Echocardiography was used to measure RV systolic and diastolic function parameters at baseline and after 6-8 weeks.ResultsIn the CPAP treatment group, RV fractional area change (FAC) improved from baseline to follow-up study (38.2 ± 10.9% to 41.4 ± 11.5%, p=0.04). In contrast, there was no change in RV FAC in the no CPAP group (43.9 ± 7.2% to 44.4 ± 7.8%, p=0.60). Tricuspid annular systolic excursion velocity, RV myocardial performance index, and tricuspid E/A and E/e’ ratios did not change in either cohort. On subgroup analysis, patients with impaired RV systolic function at baseline demonstrated an improvement in RV FAC with CPAP therapy compared to those who did not receive CPAP therapy (+5.0 ± 4.5% vs. -0.5 ± 5.2%, p=0.04). No improvement in RV FAC was observed in patients with normal RV systolic function at baseline (+1.7 ± 6.4% vs. +1.4 ± 2.0%, p=0.87).ConclusionIn patients with CHF and OSA, short-term CPAP therapy improved RV FAC but had no effect on other measures of RV systolic and diastolic function. The improvement in RV FAC with CPAP was limited to those patients with abnormal baseline RV systolic function. Further studies are required to elucidate the potential longer-term effects of CPAP therapy on RV function in CHF patients with OSA. BackgroundObstructive sleep apnea (OSA) is common in patients with congestive heart failure (CHF) and can contribute to disease progression. Continuous positive airway pressure (CPAP) is used to treat OSA and has been shown to improve left ventricular function in CHF patients. However, the effects of CPAP therapy on right ventricular (RV) function, an independent predictor of outcome in CHF patients, are not known. Obstructive sleep apnea (OSA) is common in patients with congestive heart failure (CHF) and can contribute to disease progression. Continuous positive airway pressure (CPAP) is used to treat OSA and has been shown to improve left ventricular function in CHF patients. However, the effects of CPAP therapy on right ventricular (RV) function, an independent predictor of outcome in CHF patients, are not known. MethodsIn this randomized controlled trial, 45 patients with OSA (apnea/hypopnea index >10 events/hour by nocturnal polysomnography) and stable CHF (left ventricular ejection fraction ≤45% and at least NYHA Class II symptoms) were randomized to receive CPAP (n=22) or no CPAP (n=23) therapy. Echocardiography was used to measure RV systolic and diastolic function parameters at baseline and after 6-8 weeks. In this randomized controlled trial, 45 patients with OSA (apnea/hypopnea index >10 events/hour by nocturnal polysomnography) and stable CHF (left ventricular ejection fraction ≤45% and at least NYHA Class II symptoms) were randomized to receive CPAP (n=22) or no CPAP (n=23) therapy. Echocardiography was used to measure RV systolic and diastolic function parameters at baseline and after 6-8 weeks. ResultsIn the CPAP treatment group, RV fractional area change (FAC) improved from baseline to follow-up study (38.2 ± 10.9% to 41.4 ± 11.5%, p=0.04). In contrast, there was no change in RV FAC in the no CPAP group (43.9 ± 7.2% to 44.4 ± 7.8%, p=0.60). Tricuspid annular systolic excursion velocity, RV myocardial performance index, and tricuspid E/A and E/e’ ratios did not change in either cohort. On subgroup analysis, patients with impaired RV systolic function at baseline demonstrated an improvement in RV FAC with CPAP therapy compared to those who did not receive CPAP therapy (+5.0 ± 4.5% vs. -0.5 ± 5.2%, p=0.04). No improvement in RV FAC was observed in patients with normal RV systolic function at baseline (+1.7 ± 6.4% vs. +1.4 ± 2.0%, p=0.87). In the CPAP treatment group, RV fractional area change (FAC) improved from baseline to follow-up study (38.2 ± 10.9% to 41.4 ± 11.5%, p=0.04). In contrast, there was no change in RV FAC in the no CPAP group (43.9 ± 7.2% to 44.4 ± 7.8%, p=0.60). Tricuspid annular systolic excursion velocity, RV myocardial performance index, and tricuspid E/A and E/e’ ratios did not change in either cohort. On subgroup analysis, patients with impaired RV systolic function at baseline demonstrated an improvement in RV FAC with CPAP therapy compared to those who did not receive CPAP therapy (+5.0 ± 4.5% vs. -0.5 ± 5.2%, p=0.04). No improvement in RV FAC was observed in patients with normal RV systolic function at baseline (+1.7 ± 6.4% vs. +1.4 ± 2.0%, p=0.87). ConclusionIn patients with CHF and OSA, short-term CPAP therapy improved RV FAC but had no effect on other measures of RV systolic and diastolic function. The improvement in RV FAC with CPAP was limited to those patients with abnormal baseline RV systolic function. Further studies are required to elucidate the potential longer-term effects of CPAP therapy on RV function in CHF patients with OSA. In patients with CHF and OSA, short-term CPAP therapy improved RV FAC but had no effect on other measures of RV systolic and diastolic function. The improvement in RV FAC with CPAP was limited to those patients with abnormal baseline RV systolic function. Further studies are required to elucidate the potential longer-term effects of CPAP therapy on RV function in CHF patients with OSA." @default.
- W2529609502 created "2016-10-14" @default.
- W2529609502 creator A5001552781 @default.
- W2529609502 creator A5011645780 @default.
- W2529609502 creator A5012346473 @default.
- W2529609502 creator A5013807033 @default.
- W2529609502 creator A5050890781 @default.
- W2529609502 creator A5051748961 @default.
- W2529609502 creator A5057399508 @default.
- W2529609502 creator A5059422015 @default.
- W2529609502 creator A5061437229 @default.
- W2529609502 creator A5063447489 @default.
- W2529609502 creator A5067414342 @default.
- W2529609502 creator A5078848881 @default.
- W2529609502 creator A5085854744 @default.
- W2529609502 creator A5090811516 @default.
- W2529609502 date "2015-10-01" @default.
- W2529609502 modified "2023-09-25" @default.
- W2529609502 title "THE EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE ON RV FUNCTION IN PATIENTS WITH CHF AND OSA: A RANDOMIZED CONTROL TRIAL" @default.
- W2529609502 doi "https://doi.org/10.1016/j.cjca.2015.07.429" @default.
- W2529609502 hasPublicationYear "2015" @default.
- W2529609502 type Work @default.
- W2529609502 sameAs 2529609502 @default.
- W2529609502 citedByCount "0" @default.
- W2529609502 crossrefType "journal-article" @default.
- W2529609502 hasAuthorship W2529609502A5001552781 @default.
- W2529609502 hasAuthorship W2529609502A5011645780 @default.
- W2529609502 hasAuthorship W2529609502A5012346473 @default.
- W2529609502 hasAuthorship W2529609502A5013807033 @default.
- W2529609502 hasAuthorship W2529609502A5050890781 @default.
- W2529609502 hasAuthorship W2529609502A5051748961 @default.
- W2529609502 hasAuthorship W2529609502A5057399508 @default.
- W2529609502 hasAuthorship W2529609502A5059422015 @default.
- W2529609502 hasAuthorship W2529609502A5061437229 @default.
- W2529609502 hasAuthorship W2529609502A5063447489 @default.
- W2529609502 hasAuthorship W2529609502A5067414342 @default.
- W2529609502 hasAuthorship W2529609502A5078848881 @default.
- W2529609502 hasAuthorship W2529609502A5085854744 @default.
- W2529609502 hasAuthorship W2529609502A5090811516 @default.
- W2529609502 hasConcept C126322002 @default.
- W2529609502 hasConcept C164705383 @default.
- W2529609502 hasConcept C168563851 @default.
- W2529609502 hasConcept C2775867611 @default.
- W2529609502 hasConcept C2776006263 @default.
- W2529609502 hasConcept C2776377968 @default.
- W2529609502 hasConcept C2778198053 @default.
- W2529609502 hasConcept C2778205975 @default.
- W2529609502 hasConcept C2779547634 @default.
- W2529609502 hasConcept C2781326671 @default.
- W2529609502 hasConcept C71924100 @default.
- W2529609502 hasConcept C78085059 @default.
- W2529609502 hasConceptScore W2529609502C126322002 @default.
- W2529609502 hasConceptScore W2529609502C164705383 @default.
- W2529609502 hasConceptScore W2529609502C168563851 @default.
- W2529609502 hasConceptScore W2529609502C2775867611 @default.
- W2529609502 hasConceptScore W2529609502C2776006263 @default.
- W2529609502 hasConceptScore W2529609502C2776377968 @default.
- W2529609502 hasConceptScore W2529609502C2778198053 @default.
- W2529609502 hasConceptScore W2529609502C2778205975 @default.
- W2529609502 hasConceptScore W2529609502C2779547634 @default.
- W2529609502 hasConceptScore W2529609502C2781326671 @default.
- W2529609502 hasConceptScore W2529609502C71924100 @default.
- W2529609502 hasConceptScore W2529609502C78085059 @default.
- W2529609502 hasIssue "10" @default.
- W2529609502 hasLocation W25296095021 @default.
- W2529609502 hasOpenAccess W2529609502 @default.
- W2529609502 hasPrimaryLocation W25296095021 @default.
- W2529609502 hasRelatedWork W1505332042 @default.
- W2529609502 hasRelatedWork W2113982368 @default.
- W2529609502 hasRelatedWork W2114646836 @default.
- W2529609502 hasRelatedWork W2133481293 @default.
- W2529609502 hasRelatedWork W2167944550 @default.
- W2529609502 hasRelatedWork W2186067015 @default.
- W2529609502 hasRelatedWork W2916039614 @default.
- W2529609502 hasRelatedWork W3210845737 @default.
- W2529609502 hasRelatedWork W4228999780 @default.
- W2529609502 hasRelatedWork W4283761495 @default.
- W2529609502 hasVolume "31" @default.
- W2529609502 isParatext "false" @default.
- W2529609502 isRetracted "false" @default.
- W2529609502 magId "2529609502" @default.
- W2529609502 workType "article" @default.